Due to the recent rise and concern of Coronavirus, we are taking every measure to protect our patients. In addition to following CDC guidelines, please note that we will only be allowing new or active female and male patients in our facility at this time. For any upcoming procedures, we will only allow one escort for transportation into the facility.
We are now offering virtual consultations through ferTELEty©, Kofinas Fertility Group's telemedicine program!
Getting pregnant can be tough no matter what, but for those dealing with blocked Fallopian tubes, the challenges may be a bit more difficult to overcome.
Essentially, Fallopian tubes must be open, have no swelling, and be free of scar tissue to function properly. With at least one tube in a healthy condition, having a natural or IUI-assisted pregnancy is certainly possible. On the other hand, if both tubes are experiencing problems, there are several procedures that can be done to mitigate issues and achieve positive results.
Here's what you need to know about blocked Fallopian tubes and how to increase your chances of starting a family with fertility treatment options:
Blockages can occur in the Fallopian tubes for a number of reasons, but the most common cause is pelvic inflammatory disease (PID).
Typically the result of a sexually transmitted disease, PID is a bacterial infection of the reproductive organs that affects the uterus and Fallopian tubes. The infection may lead to pelvic pain, abscess growth, scarring from adhesions, and may even cause an ectopic pregnancy if left untreated.
Additional causes of blocked Fallopian tubes include an ongoing or past experience of...
There are several ways to test for Fallopian tube blockages that are fairly routine without too much recovery time afterward.
Three main procedures that check for tubal swelling or obstructions are hysterosonograms (HSN), hysterosalpingograms (HSG), and laparoscopy with chromotubation of the tubes.
An HSN is a type of high-resolution ultrasound used with saline solution, rather than dyes and x-rays.
The process is less demanding on the body and offers a clear visual representation of the uterus, allowing a specialist to see any abnormalities within it. However, gaining a thorough look into the Fallopian tubes is somewhat limited.
An HSG provides a more in-depth look into the Fallopian tubes through the use of an iodine liquid filled into the uterus, which is contrasted by an x-ray that shows you how the liquid moves throughout your reproductive system.
This process is fairly quick altogether, typically taking less than 10 minutes, and patients can return home shortly after. With that in mind, it has been known to cause cramping and may be a secondary course of action for those who need further review of their Fallopian tubes.
Being the most demanding procedure of the three, a laparoscopy with chromotubation is an inpatient procedure carried out with general anesthesia.
Two incisions are made, one for a fine telescope (laparoscopy) to be inserted into the abdomen, and another in the pubic region for a small probe to provide an obstructed view of the reproductive organs. Once everything is in place, the chromotubation process (dye test) begins, filling the womb with a light-blue liquid. If the Fallopian tubes are open, then the dye will spill from the ends into the pelvis area, but if nothing comes out, then a blockage is usually the issue.
After this procedure, it takes approximately one week to recover.
Similar to laparoscopy with chromotubation, blockages within the Fallopian tubes can be temporarily fixed with a process called tubal cannulation.
Tubal cannulation uses two types of surgical procedures called hysteroscopy and laparoscopy.
Through a small incision of the abdomen, a narrow tube outfitted with a camera and light source is inserted into the womb. Next, a thin wire (cannula) is guided through the Fallopian tube, creating an opening and clearing blockages. Once complete, a dye is sent through the womb to see if it can pass through the Fallopian tubes without being deterred. It if flows freely, the surgery is a success.
According to research from Saint Mary's Hospital in the UK, 75% of women who undergo tubal cannulation are successful in getting pregnant between 22% and 33% of the time. However, a downside to the procedure is that Fallopian tubes cannot be reopened permanently and may reclose at a later date.
Yes, you can get pregnant naturally or with the assistance of an IUI with one Fallopian tube open. However, if both tubes are blocked, then an in vitro fertilization (IVF) may be required.
In vitro fertilization (IVF) works around blocked Fallopian tubes by developing the embryo outside of the body in a controlled laboratory setting and transferring it to the uterus through a small insemination catheter. Over time, the embryo grows naturally in the same fashion as a traditional pregnancy without relying on the Fallopian tubes to function.
With that in mind, a condition known as hydrosalpinx (swollen tubes) can have an effect on the outcome of an IVF, leading to a 50% reduction of its success. Also, anyone who has had a tubal ligation (tubes tied) may have trouble finding success with an IVF, although a tubal reversal is possible.
In any case, it's always best to consult with a fertility specialist before deciding to undergo any procedures.
At Kofinas Fertility Group, your health is always a priority, and any challenges you may have with blocked Fallopian tubes will be fully assessed to ensure the right course of action that leads to you having the family of your dreams.
NEW YORK, April 17, 2019 /PRNewswire/ -- Kofinas Fertility Group (https://www.kofinasfertility.com), a leading New York City fertility care practice, announced today that it has opened the Manhattan Reproductive Surgery Center ("MRSC") at 65 Broadway in Lower Manhattan. This 10,000 sq. ft. state-of-the-art facility is the first standalone reproductive ambulatory surgery center in New York State dedicated to the treatment of endometriosis, uterine fibroids, and expands on the Kofinas Fertility Group's comprehensive in-house advanced fertility treatment capabilities.
With the recent adoption by New York State of the Fair Access to Fertility Treatment Act (FAFTA) that goes into effect in January 2020, MRSC will offer an optimal environment from a safety, quality of care and cost perspective, for patients needing IVF and/or fertility preservation procedures. Beginning next January, all IVF and fertility preservation surgeries performed at MRSC, under the FAFTA law, will be covered by all commercial health insurance options in companies with at least 100 employees. MRSC was designed with safety as the top priority for patients undergoing reproductive surgery and infertility procedures.
MRSC reflects Kofinas Fertility Group's longstanding commitment to provide consistent high-quality outpatient care to patients suffering from a wide scope of gynecological conditions, including fibroids, endometriosis, pelvic pain, congenital abnormalities of the uterus, and infertility – all while ensuring that their future fertility remains a top priority. In addition to the practice's breadth of fertility expertise, every physician on MRSC team is personally trained by Dr. George Kofinas – an international leader in fertility medicine renowned for his success in solving complex fertility cases.
"MRSC was built with one purpose in mind: to enhance every aspect of a patient's surgical experience and optimize her reproductive health," said Dr. George Kofinas, Founder and Medical Director of Kofinas Fertility Group. "In addition to the convenience of offering patients the full range of advanced fertility treatment capabilities under one roof – including lab testing, examinations, and surgery – this centralized approach to fertility care significantly improves patient outcomes.
MRSC – Facility Overview
The new facility is 100% Green – All the materials used at MRSC have been selected based on their level of VOCs (volatile organic compounds) and other chemicals emitted from their surfaces. Each of these materials emit a minimal amount of those chemicals at a much lower level than government standards. All the instruments used in surgery are made of high quality metal alloys (steel or titanium) thus reducing the environmental impact and pollution associated with the disposition of disposable plastic instruments. This along with state of the art equipment including integrated operating rooms, patient safety systems and some of the most advanced laparoscopic equipment on the market makes MRSC an international surgical destination for gynecologic and infertility procedures.
About Kofinas Fertility Group
Founded in 1987, Kofinas Fertility Group is a leading fertility clinic with locations in Manhattan, Brooklyn and Staten Island. The group's diverse team of seven physicians has over 90 years of combined experience in fertility medicine and a stellar track record of success, including having helped bring more than 25,000 babies in the world. Always on the cutting edge of fertility medicine, Kofinas Fertility Group has achieved a number of Brooklyn's "firsts", including the first IVF procedure and birth, successful gamete intrafallopian transfer birth, successful ICSI birth, assisted hatching procedure and birth, birth from frozen eggs and embryos, birth from a donated egg, and the establishment of the first egg and embryo cryopreservation program, as well as egg donation program.
About George Kofinas, MD, FACOG
Dr. George Kofinas is a pioneer in the field of reproductive surgery and medicine with a double board certification in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. Dr. Kofinas is the founder and Medical Director of Kofinas Fertility Group, one of the first IVF centers in New York City. With over thirty years of experience in fertility medicine as the Chief of Reproductive Endocrinology and Infertility at New York Methodist Hospital and Brooklyn Hospital in Brooklyn, NY, Dr. George Kofinas' approach to patient care begins with patience and compassion. Dr. Kofinas is a member of the American Society of Reproductive Medicine, the Society for Assisted Reproductive Technologies, Society of Reproductive Endocrinology and Infertility and the Society of reproductive Surgeons. He has written and lectured extensively on the full spectrum of assisted reproductive technologies, including reproductive surgery and in vitro fertilization (IVF).
Joannie Danielides – 917-539-4924 / firstname.lastname@example.org
MRSC facility phone number is 212.818.0001.
View original content to download multimedia:http://www.prnewswire.com/news-releases/kofinas-fertility-group-opens-first-standalone-reproductive-ambulatory-surgical-center-in-new-york-state-300833446.html
SOURCE Kofinas Fertility Group
Copyright (C) 2019 PR Newswire. All rights reserved